Jagsonpal Pharmaceuticals Ltd Cash Flow Statement: Consolidated Financial Analysis & Historical Data (15 Years)

Cash Flow

Jagsonpal Pharma Cash flow Statement

Figures in Cr

Standaloned Cash Flow Results

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Figures in INR Cr
Seasonal companies are compared with the same quarter last year

Compare Cash Flow Results of Jagsonpal Pharma

Select Peers

Figures in Cr

standaloned Cash Flow Results

Change(INR)

Change(%)

Profit Before Tax

69.86

64.65

5.00

8.06%

Adjustment

-11.94

-10.97

-1.00

-8.84%

Changes In working Capital

5.52

-15.92

20.00

134.67%

Cash Flow after changes in Working Capital

63.44

37.77

26.00

67.96%

Cash Flow from Operating Activities

55.3

23.31

32.00

137.24%

Cash Flow from Investing Activities

-45.15

-18.38

-27.00

-145.65%

Cash Flow from Financing Activities

-11.7

-67.59

56.00

82.69%

Net Cash Inflow / Outflow

-1.55

-62.66

61.00

97.53%

Opening Cash & Cash Equivalents

12.76

63.35

-51.00

-79.86%

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

0.00%

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

0.00%

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

0.00%

Effect of Foreign Exchange Fluctuations

0.00

0.00%

Closing Cash & Cash Equivalent

11.22

0.69

11.00

1526.09%

Cash Flow - Snapshot (Standalone) - Mar'25

YoY Growth in year ended Mar 2025 is 57.24% vs -24.62% in Mar 2024

Mar'25

Mar'24

Change(%)

Cash Flow from Operating Activities

55.30

35.17

57.24%